De-escalation of Neoadjuvant Chemotherapy for HER2-Positive Breast Cancer: A Systematic Review and Meta-Analysis of Taxane, Trastuzumab, and Pertuzumab With or Without Carboplatin
Maria Clara Périco Perez, Gabriel Dziurkovski Machado et al. - Unknown